Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.
De Rosa C, Iommelli F, De Rosa V, Ercolano G, Sodano F, Tuccillo C, Amato L, Tirino V, Ariano A, Cimmino F, di Guida G, Filosa G, di Liello A, Ciardiello D, Martinelli E, Troiani T, Napolitano S, Martini G, Ciardiello F, Papaccio F, Morgillo F, Della Corte CM. De Rosa C, et al. Among authors: troiani t. Biomedicines. 2024 Apr 5;12(4):809. doi: 10.3390/biomedicines12040809. Biomedicines. 2024. PMID: 38672164 Free PMC article.
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.
Ciardiello F, Caputo R, Damiano V, Caputo R, Troiani T, Vitagliano D, Carlomagno F, Veneziani BM, Fontanini G, Bianco AR, Tortora G. Ciardiello F, et al. Among authors: troiani t. Clin Cancer Res. 2003 Apr;9(4):1546-56. Clin Cancer Res. 2003. PMID: 12684431
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor.
Tuccillo C, Romano M, Troiani T, Martinelli E, Morgillo F, De Vita F, Bianco R, Fontanini G, Bianco RA, Tortora G, Ciardiello F. Tuccillo C, et al. Among authors: troiani t. Clin Cancer Res. 2005 Feb 1;11(3):1268-76. Clin Cancer Res. 2005. PMID: 15709198
Antiangiogenic drugs in non-small cell lung cancer treatment.
Cascone T, Troiani T, Morelli MP, Gridelli C, Ciardiello F. Cascone T, et al. Among authors: troiani t. Curr Opin Oncol. 2006 Mar;18(2):151-5. doi: 10.1097/01.cco.0000208788.99570.0e. Curr Opin Oncol. 2006. PMID: 16462184 Review.
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases.
Morelli MP, Cascone T, Troiani T, Tuccillo C, Bianco R, Normanno N, Romano M, Veneziani BM, Fontanini G, Eckhardt SG, De Pacido S, Tortora G, Ciardiello F. Morelli MP, et al. Among authors: troiani t. J Cell Physiol. 2006 Aug;208(2):344-53. doi: 10.1002/jcp.20666. J Cell Physiol. 2006. PMID: 16688779
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy.
Ciardiello F, Troiani T, Bianco R, Orditura M, Morgillo F, Martinelli E, Morelli MP, Cascone T, Tortora G. Ciardiello F, et al. Among authors: troiani t. Ann Oncol. 2006 Jun;17 Suppl 7:vii109-14. doi: 10.1093/annonc/mdl962. Ann Oncol. 2006. PMID: 16760272 Free article. Review.
Erlotinib in cancer treatment.
Bareschino MA, Schettino C, Troiani T, Martinelli E, Morgillo F, Ciardiello F. Bareschino MA, et al. Among authors: troiani t. Ann Oncol. 2007 Jun;18 Suppl 6:vi35-41. doi: 10.1093/annonc/mdm222. Ann Oncol. 2007. PMID: 17591829 Free article. Review.
196 results